Human Papillomavirus. Papillomavirus as the cause of diseases classified to other chapters
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Having written informed consent to participate in the study age range of 15-49 years and married The husband knowing that his wife is infected with HPV disease The husband is infected with HPV disease Having Iranian nationality Being a resident of Urmia Having at least fifth grade literacy Definite diagnosis (by a gynecologist) during the last three months with HPV type The absence of malignant diseases Living with husband
Exclusion criteria
Exclusion criteria: Occurrence of pregnancy during the study Unwillingness to cooperate in the continuation of the project Not participating in more than two educational intervention sessions Getting divorced and separated from the husband Not having sex during life Having an acute psychological incident such as losing a family member Having mental illnesses such as severe depression and consuming addictive substances during the study and the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General psycho-social burden score of women infected with human papillomavirus. Timepoint: Measuring the general psycho-social burden score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Gross's emotional regulation strategies. Timepoint: Measurement of the Gross's emotional regulation strategies score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: Gross's emotion regulation questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Worries and concerns. Timepoint: Measurement of the Worries and concerns score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Emotional impact. Timepoint: Measurement of the emotional impact score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Sexual impact. Timepoint: Measurement of the sexual impact score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Self image. Timepoint: Measurement of the self image score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Partner and transmission. Timepoint: Measurement of the partner and transmission score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Interactions with doctors. Timepoint: Measurement of the interactions with doctors score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Control/life impact. Timepoint: Measurement of the control/life impact score of infected women at the beginning of the study (before the start of the intervention) and 5 weeks later at the end of the last counseling session and 3 months later. Method of measurement: HIP questionnaire.;Cognitive | — |
Countries
Iran (Islamic Republic of)
Contacts
Oroumia University of Medical Sciences